Impact of GHS in Latin America

EHS compliance throughout Latin America has become a high point of interest by companies in the region due to the increase in regulations and enforcement activities.  The view and expansion process of EHS regulations across Latin America is not the same, especially, during GHS implementation. We will briefly discuss the impact of GHS in the region and its most recent developments.


Date: November 8, 2018

Time: 11:00 am - 11:30 am (EST)

Duration: 30 minutes

  • English

Presenter(s): Edgar Rodriguez Sierra

Senior Regulatory Compliance Specialist

Edgar Rodriguez Sierra is a Senior Regulatory Compliance Specialist at UL with more than 18 years of professional experience in industrial safety and hygiene, with an emphasis on the health and industries sectors. He has an extensive knowledge of substance classification, REACH, and the Globally Harmonized System of Classification and Labeling of Chemical Products (GHS), and has worked on the exchange of GHS, REACH, and other regulatory information with governmental coordinators in Latin America.

In addition to this, Edgar has more than 12 years of environmental, toxicological, clinical and analytical experience, specialising in narcotics, bio-analysis, asbestos, lead, and air quality in laboratories in Germany, Italy, and the United States. He has a fluent technical and conversational grasp of environmental regulations in Spanish, English, Italian, Portuguese and French, and as an accomplished public speaker, Edgar is frequently invited to give Technical Seminars and Presentations at Chemical conferences and summits across the globe.


The views, opinions and technical analyses presented here are those of the author, and are not necessarily those of UL LLC. All content is subject to copyright and may not be reproduced without prior authorization from UL. While the editors of this site may verify the accuracy of its content from time to time, we assume no responsibility for errors made by the author, editorial staff or any other contributor.